.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Medtronic
Moodys
QuintilesIMS
AstraZeneca
Queensland Health
Express Scripts
Chinese Patent Office
Chubb

Generated: July 24, 2017

DrugPatentWatch Database Preview

Drug Master Files for: chymotrypsin

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
351III11/2/1959PRINCETON LAB PRODS COTRYPSIN, CHYMOTRYPSIN & RIBONUCLEASE - 'G PROCEDURES & ASSAYS
367III2/17/1960WAITAKI INTERNATIONAL BIOSCIENCES SUB WAITAKI CANADA LTDTRYPSIN & a - CHYMOTRYPSIN - PREPARTION & ASSAY METHODS
407III11/7/1960WORTHINGTON BIOCHEM CORPCHYMOTRYPSIN (MANUF PROCEDURE)
490III6/22/1962ELANCO DIV ELI LILLY AND COCHYMOTRYPSIN TRYPSIN CRYSTALLIZED
553III5/17/1963ARMOUR PHARMACEUTICAL COCHYMOTRYPSIN CRYSTALLIZED
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Argus Health
US Army
Julphar
Queensland Health
Chubb
Daiichi Sankyo
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot